The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and it comprises a spectrum of hepatic abnormalities from simple hepatic steatosis to steatohepatitis, fibrosis, cirrhosis, and liver cancer. While the pathogenesis of NAFLD remains incompletely understood, a multihit model has been proposed that accommodates causal factors from a variety of sources, including intestinal and adipose proinflammatory stimuli acting on the liver simultaneously. Prior cellular and molecular studies of patient and animal models have characterized several common pathogenic mechanisms of NAFLD, including proinflammation cytokines, lipotoxicity, oxidative stress, and endoplasmic reticulum stress. In recent years, gut microbiota has gained much attention, and dysbiosis is recognized as a crucial factor in NAFLD. Moreover, several genetic variants have been identified through genome-wide association studies, particularly rs738409 (Ile748Met) in PNPLA3 and rs58542926 (Glu167Lys) in TM6SF2, which are critical risk alleles of the disease. Although a high-fat diet and inactive lifestyles are typical risk factors for NAFLD, the interplay between diet, gut microbiota, and genetic background is believed to be more important in the development and progression of NAFLD. This review summarizes the common pathogenic mechanisms, the gut microbiota relevant mechanisms, and the major genetic variants leading to NAFLD and its progression.

[1]  P. Brun,et al.  Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[2]  Greger Lindberg,et al.  Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up , 2010, Hepatology.

[3]  A. Suzuki,et al.  Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease , 2010, Hepatology.

[4]  L. Velloso,et al.  Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. , 2007, The Journal of endocrinology.

[5]  L. Adorini,et al.  Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease* , 2013, The Journal of Biological Chemistry.

[6]  C. McClain,et al.  Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease , 2014, International journal of hepatology.

[7]  Jamey D. Young,et al.  Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. , 2013, Progress in lipid research.

[8]  F. Bellanti,et al.  Alterations of hepatic ATP homeostasis and respiratory chain during development of non‐alcoholic steatohepatitis in a rodent model , 2008, European journal of clinical investigation.

[9]  H. Tilg The Role of Cytokines in Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.

[10]  C. Kahn,et al.  Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. , 2015, Cell metabolism.

[11]  Lixin Zhu,et al.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.

[12]  R. Kreis,et al.  Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans , 2013, Obesity.

[13]  Franca Fagioli,et al.  Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. , 2011, Journal of hepatology.

[14]  Tutut Herawan,et al.  Computational and mathematical methods in medicine. , 2006, Computational and mathematical methods in medicine.

[15]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[16]  C. McClain,et al.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. , 2015, Clinical biochemistry.

[17]  M. Kleerebezem,et al.  Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[18]  J. Stockman,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2012 .

[19]  D. Schuppan,et al.  Non‐alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches , 2013, Journal of gastroenterology and hepatology.

[20]  M. Pagliassotti,et al.  Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. , 2006, Endocrinology.

[21]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[22]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[23]  C. Rogenstein,et al.  Dietary and physical activity patterns in children with fatty liver , 2010, European Journal of Clinical Nutrition.

[24]  Dermot F. Reilly,et al.  The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. , 2016, Gastroenterology.

[25]  C. Day Non-alcoholic fatty liver disease: current concepts and management strategies. , 2006, Clinical medicine.

[26]  F. Bäckhed,et al.  Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.

[27]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[28]  A. Diehl,et al.  Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis , 2001, American Journal of Gastroenterology.

[29]  R. DeFronzo,et al.  Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease , 2013, Nutrients.

[30]  J. Nicholson,et al.  Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. , 2014, Gastroenterology.

[31]  M. Orho-Melander,et al.  Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2. , 2015, Journal of hepatology.

[32]  P. Angulo Long‐term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance? , 2010, Hepatology.

[33]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Antoun,et al.  Hepatic TLR4 signaling in obese NAFLD. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[35]  S. Lang,et al.  Nonalcoholic fatty liver disease – current status and future directions , 2015, Journal of digestive diseases.

[36]  E. Elinav,et al.  NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion , 2014, Cell.

[37]  Barbara M. Bakker,et al.  The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.

[38]  A. Sanyal,et al.  Lipotoxicity in NASH. , 2012, Journal of hepatology.

[39]  P. Lampertico,et al.  Patatin‐like phospholipase domain‐containing 3 I148M affects liver steatosis in patients with chronic hepatitis B , 2013, Hepatology.

[40]  D. Albanes,et al.  PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity. , 2015, The Journal of nutrition.

[41]  E. Parks,et al.  Dietary sugars stimulate fatty acid synthesis in adults. , 2008, The Journal of nutrition.

[42]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[43]  C. Stokes,et al.  HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance. , 2015, Journal of hepatology.

[44]  D. Russell The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[45]  E. Vanni,et al.  PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non‐obese subjects with hepatitis C , 2015, Alimentary pharmacology & therapeutics.

[46]  S. McCall,et al.  Fructose consumption as a risk factor for non-alcoholic fatty liver disease. , 2008, Journal of hepatology.

[47]  L. Makowski,et al.  The inflammation highway: metabolism accelerates inflammatory traffic in obesity , 2012, Immunological reviews.

[48]  E. Paschetta,et al.  TM6SF2 may drive postprandial lipoprotein cholesterol toxicity away from the vessel walls to the liver in NAFLD. , 2016, Journal of hepatology.

[49]  D. Jenden,et al.  Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation , 1995, Hepatology.

[50]  L. N. Valenti,et al.  Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant. , 2015, The Journal of clinical endocrinology and metabolism.

[51]  S. Baker,et al.  Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis , 2014, Journal of gastroenterology and hepatology.

[52]  N. Kapel,et al.  Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. , 2016, Clinical nutrition.

[53]  Amalia Gastaldelli,et al.  Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. , 2007, Gastroenterology.

[54]  C. McClain,et al.  The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. , 2012, Alcoholism, clinical and experimental research.

[55]  Dong Wang,et al.  Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. , 2006, American journal of physiology. Endocrinology and metabolism.

[56]  A. Fodor,et al.  Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. , 2011, Gastroenterology.

[57]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[58]  C. Chai,et al.  Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats , 2013, Nutrition & Metabolism.

[59]  W. An,et al.  Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance , 2011, Journal of Molecular Medicine.

[60]  L. Szweda,et al.  Modulation of mitochondrial complex I activity by reversible Ca2+ and NADH mediated superoxide anion dependent inhibition. , 2004, Biochemistry.

[61]  S. Bischoff,et al.  Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model. , 2013, The Journal of nutritional biochemistry.

[62]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[63]  J. Borén,et al.  Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease , 2015, Hepatology.

[64]  Barbara M. Bakker,et al.  Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation , 2015, Diabetes.

[65]  Q. Anstee,et al.  The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2 , 2015, Seminars in Liver Disease.

[66]  M. van der Graaf,et al.  Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia , 2011, Diabetologia.

[67]  T. D. Pugh,et al.  Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging , 2005, Science.

[68]  C. Hetz The unfolded protein response: controlling cell fate decisions under ER stress and beyond , 2012, Nature Reviews Molecular Cell Biology.

[69]  F. Schick,et al.  Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene , 2009, Diabetes.

[70]  Anne Tybjærg-Hansen,et al.  Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.

[71]  H. Tilg,et al.  Inflammatory Mechanisms in the Regulation of Insulin Resistance , 2008, Molecular medicine.

[72]  S. Sookoian,et al.  Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease , 2011, Hepatology.

[73]  P. Ravasco,et al.  Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet , 2008, Scandinavian journal of gastroenterology.

[74]  J. Hardies,et al.  Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease , 2012, Hepatology.

[75]  Xi Jin,et al.  HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD. , 2009, Journal of hepatology.

[76]  M. Ronis,et al.  Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. , 2004, The Journal of nutrition.

[77]  M. Hellerstein,et al.  A dual sugar challenge test for lipogenic sensitivity to dietary fructose. , 2011, The Journal of clinical endocrinology and metabolism.

[78]  U. Ozcan,et al.  Unfolded Protein Response Signaling and Metabolic Diseases* , 2013, The Journal of Biological Chemistry.

[79]  J. Schattenberg,et al.  Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease , 2015, Gut.

[80]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[81]  K. Clément,et al.  TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease , 2014, Nature Communications.

[82]  L. Beilin,et al.  Lower Fructose Intake May Help Protect Against Development of Nonalcoholic Fatty Liver in Adolescents With Obesity , 2014, Journal of pediatric gastroenterology and nutrition.

[83]  Ruslan Medzhitov,et al.  Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.

[84]  S. Petta,et al.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review. , 2015, World journal of gastroenterology.

[85]  Dae-Joong Kang,et al.  Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.

[86]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[87]  G. Bánhegyi,et al.  Lipotoxicity in the liver. , 2013, World journal of hepatology.

[88]  G. Musso,et al.  Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. , 2015, Trends in molecular medicine.

[89]  Q. Anstee,et al.  The genetics of NAFLD , 2013, Nature Reviews Gastroenterology &Hepatology.

[90]  D. Pessayre,et al.  Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. , 1998, Gastroenterology.

[91]  Jie Yu,et al.  Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis , 2015, PloS one.

[92]  B. Motta,et al.  Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function. , 2014, Biochimica et biophysica acta.

[93]  Christoph Handschin,et al.  Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.

[94]  M. McCarthy,et al.  Paradoxical Lower Serum Triglyceride Levels and Higher Type 2 Diabetes Mellitus Susceptibility in Obese Individuals with the PNPLA3 148M Variant , 2012, PloS one.

[95]  M. Karin,et al.  Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates , 2006, Proceedings of the National Academy of Sciences.

[96]  S. Bischoff,et al.  Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice , 2014, PloS one.

[97]  Yanqiao Zhang,et al.  Bile acid receptors in non-alcoholic fatty liver disease. , 2013, Biochemical pharmacology.

[98]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[99]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[100]  J. Browning,et al.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. , 2014, Gastroenterology.

[101]  M. Wilkinson,et al.  Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples , 1995, Applied and environmental microbiology.

[102]  P. Puri,et al.  Mechanisms of simple hepatic steatosis: not so simple after all. , 2012, Clinics in liver disease.

[103]  Z. Halpern,et al.  Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. , 2007, Journal of hepatology.

[104]  J. Dufour,et al.  Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. , 2014, Journal of hepatology.

[105]  C. Day Pathogenesis of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.

[106]  E. Quigley,et al.  The role of the gut microbiota in nonalcoholic fatty liver disease , 2010, Nature Reviews Gastroenterology &Hepatology.

[107]  S. Bischoff,et al.  Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. , 2012, The British journal of nutrition.

[108]  L. N. Valenti,et al.  PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells , 2014, Human molecular genetics.

[109]  M. Arrese,et al.  Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. , 2015, Biochimica et biophysica acta.

[110]  N. Nowak,et al.  Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis , 2010, PloS one.

[111]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[112]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[113]  A. Bast,et al.  The role of oxidative stress in non-alcoholic steatohepatitis. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[114]  M. Trauner,et al.  Bile acid receptors as targets for drug development , 2014, Nature Reviews Gastroenterology &Hepatology.

[115]  N. Lundbom,et al.  Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. , 2011, The American journal of clinical nutrition.

[116]  Josivan G. Lima,et al.  Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis. , 2015 .

[117]  D. Artis Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.

[118]  A. Nanji,et al.  Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. , 2001, The Journal of pharmacology and experimental therapeutics.

[119]  Wei Zhang,et al.  Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. , 2009, The Journal of clinical investigation.

[120]  K. Schechtman,et al.  Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. , 2010, Gastroenterology.

[121]  E. Brunt,et al.  Nonalcoholic fatty liver disease: pathology and pathogenesis. , 2010, Annual review of pathology.

[122]  S. Rabot,et al.  Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice , 2012, Gut.

[123]  J. Borén,et al.  PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[124]  K. Nelson,et al.  Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. , 2015, Gastroenterology.

[125]  PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells , 2014, Human molecular genetics.

[126]  F. Schick,et al.  The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans. , 2009, Clinical science.

[127]  J. Carvalheira,et al.  Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance , 2007, Diabetes.

[128]  W. Nseir,et al.  Soft drink consumption linked with fatty liver in the absence of traditional risk factors. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[129]  T. Saibara,et al.  Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese , 2012, PloS one.

[130]  S. Akira,et al.  Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.

[131]  D. Wasserman,et al.  Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver , 2013, Molecular and Cellular Endocrinology.

[132]  F. Lammert,et al.  PNPLA3-Associated Steatohepatitis: Toward a Gene-Based Classification of Fatty Liver Disease , 2013, Seminars in Liver Disease.

[133]  G. Gores,et al.  Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis* , 2006, Journal of Biological Chemistry.

[134]  D. Pessayre Role of mitochondria in non‐alcoholic fatty liver disease , 2007, Journal of gastroenterology and hepatology.

[135]  C. Xing,et al.  Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population , 2012, BMC Medical Genetics.

[136]  M. Laville,et al.  Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. , 2011, The Journal of nutritional biochemistry.

[137]  G. Pacini,et al.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.

[138]  Nick V. Grishin,et al.  A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis , 2009, The Journal of Biological Chemistry.

[139]  B. Fielding,et al.  The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease , 2014, Nutrients.

[140]  Jin-Wook Kim,et al.  Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea , 2014, Digestive Diseases and Sciences.

[141]  M. Clemens,et al.  Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[142]  T. Risby,et al.  Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. , 2000, Gastroenterology.

[143]  J. Kruk,et al.  Occurrence, biosynthesis and function of isoprenoid quinones. , 2010, Biochimica et biophysica acta.

[144]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[145]  N. Lundbom,et al.  Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. , 2011, Journal of hepatology.